Brief: Q32 Bio Inc - Mark Iwicki Resigns From Q32 Bio Board Effective Dec 31, 2025
25/04/2025 21:54
April 25 (Reuters) - Inhibikase Therapeutics Inc IKT.O: Q32 BIO INC - MARK IWICKI RESIGNS FROM Q32 BIO BOARD EFFECTIVE DEC 31, 2025 Q32 BIO INC - IWICKI RESIGNS TO FOCUS ON CEO ROLE AT INHIBIKASE THERAPEUTICS Source text: [ID:n0001193125-25-096703] Further company coverage: IKT.O ((Reuters.Briefs@thomsonreuters.com))
Recent news on Q32 Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Q32 Bio Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Q32 Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview